The Influence of L-Carnitine in the Complex Treatment of Patients with Renal Dysfunction Who Have Synchronous Chronic Coronary Artery Disease and Prostate Adenocarcinoma

Abstract

rostate cancer is the most common cancer among men worldwide. 1 Moreover prostate adenocarcinoma is the most common noncutaneous cancer diagnosed in men in the United States and the second leading cause of cancer deaths. 2 Despite the advances in the treatment of these patients in recent years, the rate of cardiovascular diseases among prostate can